\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ lateral\\ aspect\\ of\\ the\\ proximal\\ calf\\ and\\ left\\ knee\\ were\\ warm\\ to\\ touch\\ with\\ tenderness\\ elicited\\ at\\ the\\ tibial\\ tuberosity\\ and\\ pain\\ within\\ the\\ joint\\ space\\ upon\\ manipulation\\ and\\ ballottement\\ of\\ the\\ patella\\.\\ there\\ was\\ compromised\\ range\\ of\\ motion\\ of\\ the\\ left\\ knee\\,\\ both\\ passive\\ and\\ active\\,\\ secondary\\ to\\ pain\\ and\\ guarding\\.\\ \\ all\\ other\\ aspects\\ of\\ the\\ exam\\ were\\ unremarkable\\.\ \(0\)\
\-\ intraoperative\\ frozen\\ section\\ analysis\\ of\\ bone\\ biopsy\\ obtained\\ under\\ fluoroscopic\\ guidance\\ was\\ concerning\\ for\\ malignant\\ small\\ round\\ cell\\ tumor\\.\\ \\ the\\ formal\\ pathology\\ report\\ listed\\ ewing\\ sarcoma\\ as\\ the\\ most\\ likely\\ diagnosis\\.\\ immunostains\\ revealed\\ strong\\ membranous\\ cd99\\ staining\\ and\\ were\\ negative\\ for\\ myogenin\\,\\ s\\-100\\,\\ cytokeratin\\,\\ cd45\\,\\ tdt\\,\\ cd20\\,\\ and\\ cd3\\.\\ \\ chromosome\\ analysis\\ a\\ normal\\ female\\ karyotype\\ of\\ 46\\,xx\\.\\ no\\ clonal\\ abnormal\\ cells\\ were\\ identified\\.\ \(0\)\
\-\ treatment\\:\\ the\\ patient\\ was\\ enrolled\\ in\\ the\\ children\\â\\€\\™s\\ oncology\\ group\\ metastatic\\ ewings\\ protocol\\ with\\ randomization\\ between\\ autologous\\ transplant\\ and\\ standard\\ therapy\\,\\ or\\ standard\\ therapy\\ alone\\ with\\ surgery\\,\\ radiation\\,\\ and\\ chemotherapy\\.\\ she\\ was\\ admitted\\ to\\ the\\ inpatient\\ oncology\\ unit\\ and\\ began\\ anti\\-neoplastic\\ therapy\\ per\\ protocol\\ aews0331\\ with\\ vincristine\\,\\ ifosfamide\\ \\+\\ mesna\\,\\ doxyrubicin\\,\\ and\\ etoposide\\ \\(vide\\)\\.\ \(0\)\
\-\ follow\\-up\\:\\ the\\ patient\\ completed\\ six\\ rounds\\ of\\ cyctoreductive\\ therapy\\ per\\ aews0331\\ vai\\ protocol\\.\\ \\ no\\ pulmonary\\ nodule\\ was\\ detected\\ on\\ follow\\-up\\ ct\\ after\\ the\\ second\\ vide\\ cycle\\.\\ she\\ is\\ set\\ to\\ undergo\\ limb\\ reconstructive\\ surgery\\ for\\ local\\ control\\ upon\\ arrival\\ of\\ her\\ custom\\ prosthetic\\ implant\\ from\\ europe\\.\\ high\\ dose\\ chemotherapy\\ and\\ autologous\\ stem\\ cell\\ rescue\\ is\\ a\\ therapy\\ option\\ which\\ may\\ benefit\\ her\\ in\\ the\\ future\\ as\\ the\\ patient\\ underwent\\ stem\\ cell\\ harvest\\ after\\ her\\ second\\ cycle\\ of\\ chemotherapy\\.\ \(0\)\
\-\ xr\\ knee\\:\\ lucent\\ poorly\\ defined\\ lesion\\ involving\\ the\\ proximal\\ tibial\\ diaphysis\\,\\ with\\ a\\ moth\\-eaten\\ appearance\\ and\\ irregular\\ zone\\ of\\ transition\\ proximally\\ and\\ thickening\\ of\\ the\\ cortex\\ of\\ the\\ lateral\\ tibial\\ diaphysis\\.\\ there\\ is\\ also\\ periostial\\ reaction\\ extending\\ superior\\ to\\ this\\ along\\ the\\ lateral\\ aspect\\ of\\ the\\ proximal\\ tibial\\ metaphysis\\,\\ and\\ at\\ the\\ inferior\\ aspect\\ of\\ the\\ lesion\\,\\ there\\ is\\ an\\ apparent\\ codman\\â\\€\\™s\\ triangle\\.\\ there\\ is\\ also\\ bowing\\ deformity\\ of\\ the\\ proximal\\ tibia\\,\\ apex\\ medial\\.\\ there\\ is\\ suggestion\\ of\\ very\\ subtle\\ periosteal\\ reaction\\ of\\ the\\ fibular\\ diaphysis\\.\ \(0\)\
\-\ cxr\\:\\ increased\\ pulmonary\\ markings\\ with\\ no\\ focal\\ infiltrates\\.\\ no\\ clear\\ evidence\\ of\\ metastases\\ or\\ malignancy\\ is\\ seen\\.\\ \ \(0\)\
\-\ mri\\ \\(left\\ tib\\/fib\\)\\:\\ large\\ aggressive\\ appearing\\ lesion\\ involving\\ the\\ proximal\\ and\\ mid\\ tibia\\,\\ its\\ periosteum\\,\\ and\\ the\\ surrounding\\ soft\\ tissues\\ including\\ adjacent\\ musculature\\,\\ with\\ probable\\ involvement\\ of\\ the\\ proximal\\ fibular\\ cortex\\.\\ soft\\ tissue\\ abnormalities\\ extend\\ down\\ to\\ the\\ level\\ of\\ the\\ distal\\ tibial\\ metaphysis\\.\\ the\\ soft\\ tissue\\ component\\ of\\ the\\ tumor\\ measures\\ 4\\.4\\ cm\\ transverse\\ x\\ 4\\.8\\ cm\\ ap\\ x\\ 8\\.1cm\\ craniocaudal\\.\\ there\\ is\\ disruption\\ and\\ partial\\ destruction\\ of\\ the\\ proximal\\ tibial\\ cortex\\ adjacent\\ to\\ the\\ soft\\ tissue\\ component\\ described\\ above\\.\ \(0\)\
\-\ nuc\\ bone\\ scan\\:\\ abnormal\\ tracer\\ accumulation\\ is\\ present\\ in\\ the\\ left\\ tibia\\ from\\ the\\ proximal\\ metaphysis\\ to\\ the\\ mid\\ diaphysis\\.\\ \\ \\ \ \(0\)\
\-\ ct\\ chest\\/abd\\/pelvis\\:\\ nine\\ millimeter\\ nodular\\ density\\ in\\ the\\ left\\ lung\\ apex\\ with\\ a\\ second\\ three\\ millimeter\\ density\\ in\\ the\\ right\\ lower\\ lobe\\.\\ several\\ right\\ lower\\ quadrant\\ mesenteric\\ masses\\ measuring\\ up\\ to\\ fifteen\\ millimeters\\ are\\ consistent\\ with\\ mesenteric\\ lymph\\ nodes\\.\ \(0\)\
\-\ ewing\\ sarcoma\\ of\\ the\\ tibia\ \(0\)\
\-\ 1\\.\\ bone\\ tumor\\ \\(osteogenc\\ sarcoma\\ vs\\.\\ ewing\\ sarcoma\\)\ \(0\)\
\-\ 2\\.\\ chondrosarcoma\ \(0\)\
\-\ 3\\.\\ osteomyelitis\ \(0\)\
\-\ 4\\.\\ leukemia\\/lymphoma\ \(0\)\
\-\ 5\\.\\ septic\\ joint\ \(0\)\
\-\ 6\\.\\ soft\\ tissue\\ sarcoma\ \(0\)\
\-\ 7\\.\\ myositis\\/muscular\\ infection\ \(0\)\
\-\ 8\\.\\ knee\\ synovitis\ \(0\)\
\-\ a\\ nine\\-year\\-old\\ girl\\ with\\ no\\ significant\\ past\\ medical\\ history\\ presented\\ with\\ localized\\ left\\ lateral\\ calf\\ pain\\ of\\ one\\ month\\ duration\\.\\ there\\ was\\ increased\\ pain\\ with\\ mild\\ swelling\\,\\ warmth\\ to\\ touch\\,\\ and\\ limping\\ noted\\ three\\ days\\ prior\\ to\\ presentation\\.\\ \\ two\\ days\\ later\\ progression\\ of\\ the\\ patient\\*s\\ calf\\ pain\\ with\\ refusal\\ to\\ bear\\ weight\\ and\\ a\\ concomitant\\ low\\-grade\\ fever\\ prompted\\ a\\ visit\\ to\\ the\\ emergency\\ department\\ at\\ an\\ outside\\ facility\\ where\\ a\\ radiograph\\ of\\ the\\ knee\\ showed\\ a\\ bony\\ irregularity\\ with\\ soft\\ tissue\\ swelling\\ to\\ the\\ left\\ tibia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ the\\:\\ 0\\.3197644330372577\ \(0\)\
\-\ of\\:\\ 0\\.19244227133822397\ \(0\)\
\-\ tibial\\:\\ 0\\.18868352757720455\ \(0\)\
\-\ proximal\\:\\ 0\\.18203180781650347\ \(0\)\
\-\ tibia\\:\\ 0\\.15559878136421337\ \(0\)\
\-\ sarcoma\\:\\ 0\\.15276406609387982\ \(0\)\
\-\ and\\:\\ 0\\.15052040624250532\ \(0\)\
\-\ diaphysis\\:\\ 0\\.14181923284768314\ \(0\)\
\-\ knee\\:\\ 0\\.13053181788559967\ \(0\)\
\-\ to\\:\\ 0\\.1274736258368544\ \(0\)\
\-\ calf\\:\\ 0\\.11884856821343207\ \(0\)\
\-\ ewing\\:\\ 0\\.11784020632182562\ \(0\)\
\-\ aews0331\\:\\ 0\\.11649124603947622\ \(0\)\
\-\ vide\\:\\ 0\\.11649124603947622\ \(0\)\
\-\ soft\\:\\ 0\\.11633962114812356\ \(0\)\
\-\ millimeter\\:\\ 0\\.11131360460812927\ \(0\)\
\-\ protocol\\:\\ 0\\.10663612355271315\ \(0\)\
\-\ therapy\\:\\ 0\\.10463205867971664\ \(0\)\
\-\ there\\:\\ 0\\.10144351728194789\ \(0\)\
\-\ metaphysis\\:\\ 0\\.10038763972939806\ \(0\)\
\-\ with\\:\\ 0\\.09984450287751441\ \(0\)\
\-\ tissue\\:\\ 0\\.09552902330107993\ \(0\)\
\-\ autologous\\:\\ 0\\.09258901546868747\ \(0\)\
\-\ is\\:\\ 0\\.08976803859116081\ \(0\)\
\-\ cortex\\:\\ 0\\.08897593379316458\ \(0\)\
\-\ left\\:\\ 0\\.08696875127754518\ \(0\)\
\-\ nine\\:\\ 0\\.08530336588116277\ \(0\)\
\-\ fibular\\:\\ 0\\.08423861317020932\ \(0\)\
\-\ cycle\\:\\ 0\\.08373777897923072\ \(0\)\
\-\ second\\:\\ 0\\.08179888591991841\ \(0\)\
\-\ oncology\\:\\ 0\\.07792152273149522\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.07758464475616422\ \(0\)\
\-\ stem\\:\\ 0\\.07701976217435658\ \(0\)\
\-\ was\\:\\ 0\\.0761591480873625\ \(0\)\
\-\ were\\:\\ 0\\.07509655661847384\ \(0\)\
\-\ lateral\\:\\ 0\\.0723004092375794\ \(0\)\
\-\ touch\\:\\ 0\\.07146090930024589\ \(0\)\
\-\ aspect\\:\\ 0\\.07049033762705598\ \(0\)\
\-\ apex\\:\\ 0\\.06846209344120391\ \(0\)\
\-\ her\\:\\ 0\\.0682619279311888\ \(0\)\
\-\ analysis\\:\\ 0\\.06774045314371518\ \(0\)\
\-\ standard\\:\\ 0\\.06760089290224926\ \(0\)\
\-\ pain\\:\\ 0\\.06516444704065878\ \(0\)\
\-\ mesenteric\\:\\ 0\\.06289450919240151\ \(0\)\
\-\ cell\\:\\ 0\\.06250402282270223\ \(0\)\
\-\ component\\:\\ 0\\.06242325147090229\ \(0\)\
\-\ reaction\\:\\ 0\\.061968768093024575\ \(0\)\
\-\ per\\:\\ 0\\.06045480355619047\ \(0\)\
\-\ bone\\:\\ 0\\.05961782558961427\ \(0\)\
\-\ no\\:\\ 0\\.05921899763072882\ \(0\)\
\-\ ballottement\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ myogenin\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ tdt\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ randomization\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ cyctoreductive\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ vai\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ harvest\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ periostial\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ codman\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ osteogenc\\:\\ 0\\.05824562301973811\ \(0\)\
\-\ upon\\:\\ 0\\.057307448586500276\ \(0\)\
\-\ tumor\\:\\ 0\\.05715139385152438\ \(0\)\
\-\ cd99\\:\\ 0\\.05565680230406463\ \(0\)\
\-\ cd45\\:\\ 0\\.05565680230406463\ \(0\)\
\-\ clonal\\:\\ 0\\.05565680230406463\ \(0\)\
\-\ ifosfamide\\:\\ 0\\.05565680230406463\ \(0\)\
\-\ up\\:\\ 0\\.05404876694591944\ \(0\)\
\-\ immunostains\\:\\ 0\\.053820004775009735\ \(0\)\
\-\ xx\\:\\ 0\\.053820004775009735\ \(0\)\
\-\ mesna\\:\\ 0\\.053820004775009735\ \(0\)\
\-\ doxyrubicin\\:\\ 0\\.053820004775009735\ \(0\)\
\-\ millimeters\\:\\ 0\\.053820004775009735\ \(0\)\
\-\ refusal\\:\\ 0\\.053820004775009735\ \(0\)\
\-\ mid\\:\\ 0\\.05242241388530537\ \(0\)\
\-\ custom\\:\\ 0\\.05239527392478558\ \(0\)\
\-\ nuc\\:\\ 0\\.05239527392478558\ \(0\)\
\-\ lesion\\:\\ 0\\.0523835761235019\ \(0\)\
\-\ cd3\\:\\ 0\\.05123118405933625\ \(0\)\
\-\ enrolled\\:\\ 0\\.05123118405933625\ \(0\)\
\-\ rescue\\:\\ 0\\.05123118405933625\ \(0\)\
\-\ triangle\\:\\ 0\\.05123118405933625\ \(0\)\
\-\ involving\\:\\ 0\\.051022147902189056\ \(0\)\
\-\ formal\\:\\ 0\\.05024696010198035\ \(0\)\
\-\ karyotype\\:\\ 0\\.05024696010198035\ \(0\)\
\-\ rounds\\:\\ 0\\.05024696010198035\ \(0\)\
\-\ fifteen\\:\\ 0\\.05024696010198035\ \(0\)\
\-\ limping\\:\\ 0\\.04939438653028136\ \(0\)\
\-\ swelling\\:\\ 0\\.049026662850573687\ \(0\)\
\-\ three\\:\\ 0\\.048897675541836425\ \(0\)\
\-\ cytokeratin\\:\\ 0\\.048642363343662766\ \(0\)\
\-\ cd20\\:\\ 0\\.048642363343662766\ \(0\)\
\-\ etoposide\\:\\ 0\\.048642363343662766\ \(0\)\
\-\ europe\\:\\ 0\\.048642363343662766\ \(0\)\
\-\ density\\:\\ 0\\.04830217361894652\ \(0\)\
\-\ joint\\:\\ 0\\.04799956147234046\ \(0\)\
\-\ patient\\:\\ 0\\.04738411077959172\ \(0\)\
\-\ prosthetic\\:\\ 0\\.047361117576635046\ \(0\)\
\-\ adjacent\\:\\ 0\\.0472166144822643\ \(0\)\
\-\ frozen\\:\\ 0\\.046805565814607875\ \(0\)\
\-\ membranous\\:\\ 0\\.046805565814607875\ \(0\)\
\-\ chromosome\\:\\ 0\\.04629450773434374\ \(0\)\
\-\ xr\\:\\ 0\\.04629450773434374\ \(0\)\
\-\ days\\:\\ 0\\.0461125446323008\ \(0\)\
\-\ reconstructive\\:\\ 0\\.04582134185725197\ \(0\)\
\-\ in\\:\\ 0\\.0453022146123187\ \(0\)\
\-\ ewings\\:\\ 0\\.0445816911395797\ \(0\)\
\-\ pulmonary\\:\\ 0\\.04440094980636792\ \(0\)\
\-\ compromised\\:\\ 0\\.04387153575868691\ \(0\)\
\-\ abnormal\\:\\ 0\\.04376288527482527\ \(0\)\
\-\ she\\:\\ 0\\.04336149066478312\ \(0\)\
\-\ tuberosity\\:\\ 0\\.04323252114157848\ \(0\)\
\-\ vincristine\\:\\ 0\\.04293549933190667\ \(0\)\
\-\ periosteum\\:\\ 0\\.04293549933190667\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.04265168294058139\ \(0\)\
\-\ staining\\:\\ 0\\.04237994756987949\ \(0\)\
\-\ intraoperative\\:\\ 0\\.04211930658510466\ \(0\)\
\-\ set\\:\\ 0\\.04186888948961536\ \(0\)\
\-\ tracer\\:\\ 0\\.04186888948961536\ \(0\)\
\-\ cm\\:\\ 0\\.04183435689601608\ \(0\)\
\-\ listed\\:\\ 0\\.041627924383260906\ \(0\)\
\-\ arrival\\:\\ 0\\.04139572361252359\ \(0\)\
\-\ warmth\\:\\ 0\\.04139572361252359\ \(0\)\
\-\ concomitant\\:\\ 0\\.04139572361252359\ \(0\)\
\-\ at\\:\\ 0\\.04127038334317699\ \(0\)\
\-\ proximally\\:\\ 0\\.04117167193988618\ \(0\)\
\-\ bowing\\:\\ 0\\.04117167193988618\ \(0\)\
\-\ guidance\\:\\ 0\\.04095521671965533\ \(0\)\
\-\ warm\\:\\ 0\\.04074585968525232\ \(0\)\
\-\ elicited\\:\\ 0\\.04074585968525232\ \(0\)\
\-\ implant\\:\\ 0\\.0405431500408246\ \(0\)\
\-\ infiltrates\\:\\ 0\\.04015607289485132\ \(0\)\
\-\ bear\\:\\ 0\\.04015607289485132\ \(0\)\
\-\ prompted\\:\\ 0\\.04015607289485132\ \(0\)\
\-\ musculature\\:\\ 0\\.03961618940447736\ \(0\)\
\-\ synovitis\\:\\ 0\\.03961618940447736\ \(0\)\
\-\ increased\\:\\ 0\\.03938983828092185\ \(0\)\
\-\ suggestion\\:\\ 0\\.03928006877394187\ \(0\)\
\-\ surgery\\:\\ 0\\.0391632864784313\ \(0\)\
\-\ inpatient\\:\\ 0\\.03911841919060044\ \(0\)\
\-\ passive\\:\\ 0\\.03896076136574761\ \(0\)\
\-\ unit\\:\\ 0\\.03896076136574761\ \(0\)\
\-\ manipulation\\:\\ 0\\.03865666496533033\ \(0\)\
\-\ benefit\\:\\ 0\\.03865666496533033\ \(0\)\
\-\ patella\\:\\ 0\\.03822606469585301\ \(0\)\
\-\ transition\\:\\ 0\\.03808875150051709\ \(0\)\
\-\ strong\\:\\ 0\\.037954329325151116\ \(0\)\
\-\ aspects\\:\\ 0\\.037693688340376286\ \(0\)\
\-\ completed\\:\\ 0\\.037693688340376286\ \(0\)\
\-\ probable\\:\\ 0\\.037693688340376286\ \(0\)\
\-\ visit\\:\\ 0\\.037567252179177835\ \(0\)\
\-\ lower\\:\\ 0\\.03722267079116106\ \(0\)\
\-\ option\\:\\ 0\\.03674605369515781\ \(0\)\
\-\ future\\:\\ 0\\.036529598474926955\ \(0\)\
\-\ markings\\:\\ 0\\.036529598474926955\ \(0\)\
\-\ transplant\\:\\ 0\\.03642406189865638\ \(0\)\
\-\ limb\\:\\ 0\\.03642406189865638\ \(0\)\
\-\ facility\\:\\ 0\\.036117531796096225\ \(0\)\
\-\ fluoroscopic\\:\\ 0\\.03601854039466282\ \(0\)\
\-\ alone\\:\\ 0\\.035825046269026974\ \(0\)\
\-\ guarding\\:\\ 0\\.03563724398017952\ \(0\)\
\-\ after\\:\\ 0\\.03533716082759946\ \(0\)\
\-\ irregularity\\:\\ 0\\.0352774407650193\ \(0\)\
\-\ lucent\\:\\ 0\\.03519057115974898\ \(0\)\
\-\ zone\\:\\ 0\\.03519057115974898\ \(0\)\
\-\ accumulation\\:\\ 0\\.03519057115974898\ \(0\)\
\-\ duration\\:\\ 0\\.035104867624702794\ \(0\)\
\-\ concerning\\:\\ 0\\.0349368364141489\ \(0\)\
\-\ detected\\:\\ 0\\.0349368364141489\ \(0\)\
\-\ group\\:\\ 0\\.03461348542285904\ \(0\)\
\-\ septic\\:\\ 0\\.03461348542285904\ \(0\)\
\-\ also\\:\\ 0\\.03426309223376525\ \(0\)\
\-\ undergo\\:\\ 0\\.034012117244384105\ \(0\)\
\-\ dose\\:\\ 0\\.034012117244384105\ \(0\)\
\-\ began\\:\\ 0\\.03387022657185759\ \(0\)\
\-\ extend\\:\\ 0\\.03359556841900599\ \(0\)\
\-\ 46\\:\\ 0\\.03346254657646602\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.03339706069476582\ \(0\)\
\-\ progression\\:\\ 0\\.03339706069476582\ \(0\)\
\-\ section\\:\\ 0\\.03320453904914016\ \(0\)\
\-\ destruction\\:\\ 0\\.03320453904914016\ \(0\)\
\-\ for\\:\\ 0\\.03311706964056426\ \(0\)\
\-\ poorly\\:\\ 0\\.032896033751670356\ \(0\)\
\-\ disruption\\:\\ 0\\.032896033751670356\ \(0\)\
\-\ six\\:\\ 0\\.032717841233049105\ \(0\)\
\-\ localized\\:\\ 0\\.032717841233049105\ \(0\)\
\-\ periosteal\\:\\ 0\\.0320509938888036\ \(0\)\
\-\ aggressive\\:\\ 0\\.03149544212677642\ \(0\)\
\-\ subtle\\:\\ 0\\.031399428024298605\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.031399428024298605\ \(0\)\
\-\ local\\:\\ 0\\.03135195704357999\ \(0\)\
\-\ control\\:\\ 0\\.031119756272842674\ \(0\)\
\-\ nodes\\:\\ 0\\.030939890364749253\ \(0\)\
\-\ department\\:\\ 0\\.030808239979092333\ \(0\)\
\-\ report\\:\\ 0\\.030679249379974415\ \(0\)\
\-\ apparent\\:\\ 0\\.030469892345571407\ \(0\)\
\-\ under\\:\\ 0\\.03014857586955234\ \(0\)\
\-\ round\\:\\ 0\\.029842657837883178\ \(0\)\
\-\ children\\:\\ 0\\.029842657837883178\ \(0\)\
\-\ admitted\\:\\ 0\\.029842657837883178\ \(0\)\
\-\ deformity\\:\\ 0\\.029768414937464797\ \(0\)\
\-\ measures\\:\\ 0\\.029695025422618513\ \(0\)\
\-\ down\\:\\ 0\\.029586498999655726\ \(0\)\
\-\ described\\:\\ 0\\.029550729620419706\ \(0\)\
\-\ metastases\\:\\ 0\\.02944460832712921\ \(0\)\
\-\ as\\:\\ 0\\.029263475406769515\ \(0\)\
\-\ outside\\:\\ 0\\.029237515011060335\ \(0\)\
\-\ cxr\\:\\ 0\\.029136433994980705\ \(0\)\
\-\ appearing\\:\\ 0\\.029103092835694355\ \(0\)\
\-\ nodular\\:\\ 0\\.029004101434260954\ \(0\)\
\-\ from\\:\\ 0\\.028930010087243243\ \(0\)\
\-\ nodule\\:\\ 0\\.028747390777400045\ \(0\)\
\-\ tissues\\:\\ 0\\.028716015689721073\ \(0\)\
\-\ where\\:\\ 0\\.028622805019777663\ \(0\)\
\-\ pathology\\:\\ 0\\.02859203475543022\ \(0\)\
\-\ lymph\\:\\ 0\\.028321578522766178\ \(0\)\
\-\ range\\:\\ 0\\.02826300180461744\ \(0\)\
\-\ motion\\:\\ 0\\.028233913747497372\ \(0\)\
\-\ measuring\\:\\ 0\\.028176132199347118\ \(0\)\
\-\ irregular\\:\\ 0\\.028118868878338452\ \(0\)\
\-\ cells\\:\\ 0\\.028062114571360798\ \(0\)\
\-\ transverse\\:\\ 0\\.028062114571360798\ \(0\)\
\-\ partial\\:\\ 0\\.028062114571360798\ \(0\)\
\-\ bony\\:\\ 0\\.028062114571360798\ \(0\)\
\-\ an\\:\\ 0\\.02785478264645777\ \(0\)\
\-\ vs\\:\\ 0\\.02778567236852939\ \(0\)\
\-\ ct\\:\\ 0\\.027731878569794643\ \(0\)\
\-\ malignancy\\:\\ 0\\.02726629530663947\ \(0\)\
\-\ active\\:\\ 0\\.027045684656717816\ \(0\)\
\-\ emergency\\:\\ 0\\.027021636351472377\ \(0\)\
\-\ its\\:\\ 0\\.02695003017109748\ \(0\)\
\-\ clear\\:\\ 0\\.02640437581842246\ \(0\)\
\-\ abnormalities\\:\\ 0\\.026382621734363954\ \(0\)\
\-\ involvement\\:\\ 0\\.02636094151830523\ \(0\)\
\-\ above\\:\\ 0\\.02627494941045863\ \(0\)\
\-\ ap\\:\\ 0\\.02614809455897546\ \(0\)\
\-\ very\\:\\ 0\\.026127194974047585\ \(0\)\
\-\ including\\:\\ 0\\.026064903577576657\ \(0\)\
\-\ later\\:\\ 0\\.026064903577576657\ \(0\)\
\-\ defined\\:\\ 0\\.02598278260633938\ \(0\)\
\-\ malignant\\:\\ 0\\.025962416345069142\ \(0\)\
\-\ identified\\:\\ 0\\.025821643012813672\ \(0\)\
\-\ obtained\\:\\ 0\\.025762248933402277\ \(0\)\
\-\ girl\\:\\ 0\\.025549078929346058\ \(0\)\
\-\ biopsy\\:\\ 0\\.025530048162664968\ \(0\)\
\-\ quadrant\\:\\ 0\\.025511073951094528\ \(0\)\
\-\ weight\\:\\ 0\\.02539839777700805\ \(0\)\
\-\ or\\:\\ 0\\.025340658869372926\ \(0\)\
\-\ underwent\\:\\ 0\\.025089541269796716\ \(0\)\
\-\ presentation\\:\\ 0\\.025071830252907323\ \(0\)\
\-\ masses\\:\\ 0\\.024794938409763434\ \(0\)\
\-\ thickening\\:\\ 0\\.024778024976046375\ \(0\)\
\-\ inferior\\:\\ 0\\.024778024976046375\ \(0\)\
\-\ extending\\:\\ 0\\.024694123407425626\ \(0\)\
\-\ fever\\:\\ 0\\.024694123407425626\ \(0\)\
\-\ unremarkable\\:\\ 0\\.024416833606191148\ \(0\)\
\-\ along\\:\\ 0\\.024400891481817445\ \(0\)\
\-\ surrounding\\:\\ 0\\.024290397444992697\ \(0\)\
\-\ showed\\:\\ 0\\.02425917578133831\ \(0\)\
\-\ space\\:\\ 0\\.02424362201604715\ \(0\)\
\-\ right\\:\\ 0\\.02415035049297314\ \(0\)\
\-\ radiation\\:\\ 0\\.02413579382612708\ \(0\)\
\-\ several\\:\\ 0\\.0238959602780378\ \(0\)\
\-\ revealed\\:\\ 0\\.023881265639803407\ \(0\)\
\-\ radiograph\\:\\ 0\\.023721818097351036\ \(0\)\
\-\ medial\\:\\ 0\\.023707518388138515\ \(0\)\
\-\ past\\:\\ 0\\.023707518388138515\ \(0\)\
\-\ superior\\:\\ 0\\.02367901469126974\ \(0\)\
\-\ between\\:\\ 0\\.02366481041957255\ \(0\)\
\-\ medical\\:\\ 0\\.02314720716447124\ \(0\)\
\-\ tenderness\\:\\ 0\\.022840677061911088\ \(0\)\
\-\ negative\\:\\ 0\\.022548191534841843\ \(0\)\
\-\ lung\\:\\ 0\\.02215551121387575\ \(0\)\
\-\ month\\:\\ 0\\.02215551121387575\ \(0\)\
\-\ level\\:\\ 0\\.02200058603083417\ \(0\)\
\-\ infection\\:\\ 0\\.02200058603083417\ \(0\)\
\-\ appearance\\:\\ 0\\.021957003489635578\ \(0\)\
\-\ focal\\:\\ 0\\.021785588697924307\ \(0\)\
\-\ likely\\:\\ 0\\.02176448184400992\ \(0\)\
\-\ all\\:\\ 0\\.02168074533239156\ \(0\)\
\-\ two\\:\\ 0\\.021628962262702098\ \(0\)\
\-\ scan\\:\\ 0\\.021608366059375793\ \(0\)\
\-\ secondary\\:\\ 0\\.021587836081897956\ \(0\)\
\-\ presented\\:\\ 0\\.021238852093302566\ \(0\)\
\-\ distal\\:\\ 0\\.02116169323894525\ \(0\)\
\-\ lobe\\:\\ 0\\.021047675610958935\ \(0\)\
\-\ significant\\:\\ 0\\.021028869065713645\ \(0\)\
\-\ one\\:\\ 0\\.02085291662234252\ \(0\)\
\-\ high\\:\\ 0\\.02069949313096295\ \(0\)\
\-\ evidence\\:\\ 0\\.02067279699104795\ \(0\)\
\-\ mild\\:\\ 0\\.020646212008178944\ \(0\)\
\-\ prior\\:\\ 0\\.020377793713053195\ \(0\)\
\-\ both\\:\\ 0\\.02031031813135012\ \(0\)\
\-\ metastatic\\:\\ 0\\.019975273237089065\ \(0\)\
\-\ consistent\\:\\ 0\\.01974847694097539\ \(0\)\
\-\ noted\\:\\ 0\\.01931053165997481\ \(0\)\
\-\ most\\:\\ 0\\.01895475892273927\ \(0\)\
\-\ other\\:\\ 0\\.018914177318995064\ \(0\)\
\-\ diagnosis\\:\\ 0\\.018880555242908412\ \(0\)\
\-\ small\\:\\ 0\\.018787344572964996\ \(0\)\
\-\ mri\\:\\ 0\\.018695475110356526\ \(0\)\
\-\ present\\:\\ 0\\.01868896331224538\ \(0\)\
\-\ exam\\:\\ 0\\.01833451177376958\ \(0\)\
\-\ may\\:\\ 0\\.018328357732334554\ \(0\)\
\-\ large\\:\\ 0\\.018248890332693717\ \(0\)\
\-\ female\\:\\ 0\\.017574967786105792\ \(0\)\
\-\ treatment\\:\\ 0\\.0173494083043943\ \(0\)\
\-\ seen\\:\\ 0\\.01714686355924201\ \(0\)\
\-\ within\\:\\ 0\\.01677453786652564\ \(0\)\
\-\ which\\:\\ 0\\.01656113754448822\ \(0\)\
\-\ normal\\:\\ 0\\.014870581607894277\ \(0\)\
\-\ history\\:\\ 0\\.013915053507806075\ \(0\)\
\-\ are\\:\\ 0\\.01382023531383221\ \(0\)\
\-\ this\\:\\ 0\\.012515022175790792\ \(0\)\
\-\ on\\:\\ 0\\.010999864443154848\ \(0\)\
